Pharma Equity Group A/S Cl A Financial Flexibility Index
Pharma Equity Group A/S Cl A financial flexibility index. Pharma Equity Group A/S Cl A (PEG) has a Financial Flexibility Index of -0.40x as of December 2024. Free cash flow of Dkr-6.66 Million (operating CF Dkr-6.66 Million minus capex Dkr0.00) represents 0% of total liabilities (Dkr16.73 Million). See Pharma Equity Group A/S Cl A (PEG) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Pharma Equity Group A/S Cl A (2009–2025)
Financial flexibility index of Pharma Equity Group A/S Cl A from 2009 to 2025. Historical Financial Flexibility Index trend for Pharma Equity Group A/S Cl A across 17 annual periods. Check cash flow quality index of Pharma Equity Group A/S Cl A to evaluate the quality of earnings relative to operating cash generation.
Pharma Equity Group A/S Cl A Financial Flexibility Index by Year (2009–2025)
Pharma Equity Group A/S Cl A financial flexibility index by year from 2009 to 2025. Year-by-year free cash flow to debt coverage for Pharma Equity Group A/S Cl A. For the full cash flow conversion analysis, see how efficiently does Pharma Equity Group A/S Cl A generate cash.
| Year | Flexibility Index | Free Cash Flow (DKK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Dkr0.00 | Dkr-17.66 Million | Dkr13.43 Million | ▲ +100.0% |
| 2024 | -1.37x | Dkr-22.86 Million | Dkr-22.86 Million | Dkr16.73 Million | ▼ -250.1% |
| 2023 | -0.39x | Dkr-16.55 Million | Dkr-16.62 Million | Dkr42.40 Million | ▼ -239.9% |
| 2022 | -0.11x | Dkr-2.87 Million | Dkr-2.87 Million | Dkr25.03 Million | ▼ -15.9% |
| 2021 | -0.10x | Dkr-2.09 Million | Dkr-2.09 Million | Dkr21.08 Million | ▲ +76.7% |
| 2020 | -0.43x | Dkr-9.90 Million | Dkr-9.90 Million | Dkr23.30 Million | ▼ -427.5% |
| 2019 | 0.13x | Dkr1.78 Million | Dkr-274.00K | Dkr13.68 Million | ▲ +126.8% |
| 2018 | -0.48x | Dkr-1.58 Million | Dkr-1.58 Million | Dkr3.27 Million | ▲ +88.1% |
| 2017 | -4.07x | Dkr-4.92 Million | Dkr-4.92 Million | Dkr1.21 Million | ▼ -65060.9% |
| 2016 | -0.01x | Dkr-181.00K | Dkr-181.00K | Dkr28.98 Million | ▲ +94.3% |
| 2015 | -0.11x | Dkr-2.94 Million | Dkr-2.94 Million | Dkr26.72 Million | ▲ +40.4% |
| 2014 | -0.18x | Dkr-4.80 Million | Dkr-4.80 Million | Dkr26.02 Million | ▼ -1117.8% |
| 2013 | -0.02x | Dkr-5.40 Million | Dkr-5.79 Million | Dkr356.68 Million | ▲ +30.4% |
| 2012 | -0.02x | Dkr-10.17 Million | Dkr-10.56 Million | Dkr467.46 Million | ▼ -758.2% |
| 2011 | 0.00x | Dkr-1.08 Million | Dkr-5.71 Million | Dkr428.10 Million | ▼ -106.5% |
| 2010 | 0.04x | Dkr17.43 Million | Dkr-17.75 Million | Dkr444.20 Million | ▲ +217.2% |
| 2009 | -0.03x | Dkr-744.00K | Dkr-744.00K | Dkr22.24 Million | — |